4 IJANS Novel Bitter Melon
4 IJANS Novel Bitter Melon
4 IJANS Novel Bitter Melon
ABSTRACT
Objectives
The objectives of this study was to prepare and investigate the phytosomes of crude bitter melon and olive leaves
extracts for anti-hyperglycemic activities in glucose-induced hyperglycemic rats.
Methods
Phytosomes were prepared by reacting one mole of the phenolic compounds of each extract with two moles of
Phosphatydil-choline. Bitter melon and olive leaves phytosomes (150 and 200 mg/kg) were evaluated for oral toxicity.
Results
In the oral toxicity study, no mortality was observed among the rats received the phytosomes at the single dose of
150, 200mg/kg. Hence one tenth of the phytosomes dose tested (20mg/kg). Moreover, it is evaluated for hypoglycemic
effects by oral glucose tolerance test in induced hyperglycemic rats. In the orally glucose induced hyperglycemic rats,
phytosomes were significantly reduced serum glucose levels at 60, 90 and120 minute (P<0.001) than it is extracts.
Most significant reduction was observed at 90 minute (26%). Glibenclamide was used as standard drug.
Conclusions
Our results indicated that the bitter melon and olive leaves phytosomes is more potent in anti-hyperglycemic
activities than extracts. Clearly, further studies are warranted to improve our understanding of the underlying
mechanisms.
KEYWORDS: Bitter Melon Extract, Olive Leaves Extract, OGTT, Phytosome, Phosphatydil-Choline
www.iaset.us editor@iaset.us
32 Bandar Hamadneh, Hayder AL-Domi & Malik Haddadin
Article History
Received: 03 Apr 2018 | Revised: 09 Apr 2018 | Accepted: 13 Apr 2018
INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder reaching pandemic proportions worldwide
[1, 2]. In 2014, WHO reported that the prevalence of DM in adults aged 18 or more was 9%, 90% of them with T 2 DM
[3]. More than 382 million individuals from all age groups is diagnosed with DM, which is estimated to reach about 592
million in 2035 [4]. Although, there are many available anti-diabetic drugs such as biguanides and sulphonylureas, yet they
have several side effects, including hypoglycemia, liver toxicity, dyslipidemia, and hypertension [5]. Whereas, the natural
plants are not only recommended to use from WHO, but also more cost-effective with lower side effects as compared to
chemical drugs [6, 7].
Alternative medicine has been used widely in order to treat T2DM by using natural compounds. Nonetheless,
limited evidence exists regarding the efficacy, safety, and mechanisms of action for the used natural compounds for the
treatment of diabetes [8]. Furthermore, abundant plants products are available in the market that is useful for the treatment
of metabolic disorder, including diabetes, nonetheless, these products are water-soluble, which can be easily destroyed by
gastric acids and gut enzymes leading to a limited bioavailability [9].
The olive tree (Olea europaea L.) is cultivated in several parts of the world, but the Mediterranean region is the
superior crop production area with approximately 98% of the world’s olive cultivation [10]. Olive leaves are well known in
folk medicine to treat hyperglycemia, hypertension, and infectious diseases, especially in Europe that attributed to its high
phenolic compounds [11]. Whereas, bitter melon (Momordica charantia L.) is a tropical medicinal plant cultivated for its
edible fruit. It's a rich in phenolic and saponin compounds, which are linked with higher antioxidant activity [12].
Bitter melon is a well-known agent to decrease blood glucose levels in Asia, Africa, and Latin America, and also its
extracts had been called insulin vegetable [5].
Phytosome technology is patented technology based on a combination of various plant's extracts or water-soluble
molecules to produce complex lipid molecules called phytosome [13]. Phytosome is highly absorbable and highly
bioavailable with greater clinical benefits and without affecting the nutrient safety of the phytosome [14].
Phytosome protects the component of the herbal extracts away from destruction through digestive secretions and gut
bacteria [15].Thus, phytosome technology is an effective method of delivery used for the improvement of various dietary
supplements activity against diseases [16]. However, to best of our knowledge, studies on providing olive leaves and bitter
melon extracts in the phytosome form to treat T2DM are scarce. Thus, the objective of the current study is to prepare crude
olive leaves and bitter melon phytosomes, and to evaluate its anti-hyperglycemic activities in glucose-induced
hyperglycemic rats by OGTT.
Glibenclamide (Hikma Company, Jordan) D-glucose, ethanol (England), acetone (Lonover chemicals, England),
gallic acids (Sigma, USA. MW,170.12 g /mole). Phosphatidylcholine (Soyabean Lecithin Cargill, Belgium E 322.
MW, 677.93 g /mole).
Animals
This research was approved by the Department of Nutrition and Food Technology Committee for Animal
Experimentation/University of Jordan. 55 male Sprague-Dawley rats, weighing about 150-180 grams and 8 weeks of age
were kept at Animal Unit, Scholl of Agriculture, the University of Jordan, Jordan. Each rat was housed in a single
metabolically- ventilated plastic cage with a stainless steel wire mesh floor and front. The rats were kept under controlled
temperature (22±2ºC) and maintained at a 12:12 hours light: dark cycles (from 19:00 pm to 7:00 am) with free access to
water and standard laboratory chow for one week of acclimatization.
On Apr 2016, olive (Olea europaea) leaves were randomly and directly collected from an olive tree
(Baladi variety) from a local farm in Irbid, Northen-Jordan. The Baladi olive trees were of about 20 years old, not irrigated
and no phytosanitary treatments had been utilized for the last10 years. Collected leaves were kept in plastic bags.
The leaves were washed with running water to remove impurities such as dust, then dried under shade at room temperature
and then crush using a mechanical blender (Moulinex Miller, France) and passed through mesh cloth to get leaves powder
and stored at 4◦C until use [17].
Fresh bitter melon fruits were purchased from the local market in Irbid, Northern-Jordan. The fruits were washed
with running water to remove impurities and then dried in an oven (WTC Binder, USA) at a temperature of 37 ◦C for 5
days and then crush using a mechanical blender (Moulinex Miller, France) and passed through mesh cloth to get plants
powder and stored at 4◦C until use [18].
Fifty grams of each plant powder was extracted with 500 mL of 95% ethanol. The mixture was mixed on a rotary
shaker (New Brunswick Scientific, USA) for two hours at 180 rpm at room temperature 20 ◦C and then for 15 minutes in
an ultrasonic bath at 37 °C (Bandelin Electronic-RK-103 H, Germany). The mixture was filtered through Whatman no: 4
and then membrane filter (cellulose type filter, 0.45 µm). After filtration, the solvent was evaporated under vacuum using a
rotary evaporator (Büchi, RE 121, Switzerland) to remove solvent under reduced pressure at 38 °C and 120 rpm.
All the obtained crude extracts were then transferred to vials covered with aluminum foil and then stored in the dark at
room temperature to protect them from photo-oxidation [18, 19].
The total phenols content of olive leaves and bitter melon fruits extract were determined by Folin-Ciocalteau
assay and were expressed as gallic acid equivalent/gram of extracts (mg GAE/G) [20]. Total Flavonoids was determined by
the aluminum chloride colorimetric method [20]. Total tannins were determined by Folin and Ciocalteu method [21].
www.iaset.us editor@iaset.us
34 Bandar Hamadneh, Hayder AL-Domi & Malik Haddadin
Phytosome Preparation
Olive leaves and bitter melon phytosomes were prepared by adding 2 moles of phosphatidyl-choline for each one
mole of the total phenolic compounds of plant extracts independently. In brief, 2 moles of phosphatidyl-choline was
dissolved in a solution containing 200 ml of ethanol, and then one mole of polyphenolic compounds of plant extract was
added. The mixture was mixed on a rotary shaker (New Brunswick Scientific, USA) for two hours at 180 rpm at room
temperature. After that, ultrasonic bath (Bandelin Electronic-RK-103 H, Germany) was used to enhance the formation of
the phytosome structure at 37C for 15 minutes. The solvent was evaporated under vacuum using a rotary evaporator
(Büchi, RE 121, Switzerland) at 38 °C and 120 rpm. Finally, 50 ml of acetone was added to each mixture, and then left in
the dark at room temperature to precipitate phytosome structure [13, 22].
Microroscopic Scanning
Microscope digital camera (Nicon YS2-H, Japan) was used to confirm the formation of phytosome complex
between plant extracts and the phospholipids.
Oral toxicity test was performed according to the Organization of Economic Cooperation and Development
(OECD) guideline 425. A total of 25 male Sprague-Dawley rats were used. All rats fasted overnight, then divided into five
groups with five rats in each group. Group 1 stands as control group received distilled water. Groups (2 and 3) received a
single oral dose (150, 200mg/kg) of olive leaves phytosome respectively. Groups (4 and 5) received a single oral dose
(150 and 200mg/kg) of bitter melon fruits phytosome respectively. After the phytosomes administration, food withheld for
3-4 hours. Rats were observed post the dose at 0 min, 30 min, 1 h, 2 h, 4 h, 6 h, and every day for 14 days for general toxic
signs, morphological behavior and mortality. One tenth of the dose was taken from the OGTT [23].
A test was performed in overnight fasted normal rats. The experimental rats were divided into 6 groups of five
rats each. Fasted rats have then received D-glucose solution (2mg/kg/) orally. After thirty minutes, rats were treated as
follows: Group 1- stands for normal control group received distal water. Group 2 and 3 were received bitter melon
phytosome and extract at the dose of 20mg/kg. Group 4 standard control group received the glibenclamide drug at the dose
of 0.25mg/kg. Group 5 and 6 were received olive leaves phytosome and extract at a dose of 20mg/kg. The blood glucose
level was estimated before glucose administration (-30 min), 30 min later (0 min) and at 30, 60, 90 and 120 minutes after
administration of extracts, phytosome, and standard drug using a glucometer (ACCU-CHEK 68305 Mannheim, Germany)
[24].
STATISTICAL ANAYLSIS
Experimental values are expressed as mean ± SEM. One–Way Analysis of Variance (ANOVA) was used.
All Pair-wise comparisons were made using Duncan’s Multiple Range Test (DMRT) post-hoc test. Statistical significance
was considered to be indicated by a p-value (p<0.001).
RESULTS
Total Phenol Content
Table 1 shows the total phenolics, flavonoids, and catechin of olive leaves extract and bitter melon extract.
The highest value was recorded in olive leaves extract.
Microscopic Scanning
A Microscopic scan showed that the phytosome is a complex cell- like structure in which phyto-constituents of
the plants extract present on the inner surface of the phytosome and enveloped by PC (Figure 1).
No mortality was observed among the rats received olive leaves and bitter melon phytosomes at the single dose of
150 and 200mg/kg. Hence, one-tenth of the tested phytosome dose was selected (i.e., 20mg/kg).
OGTT
Hyperglycemia induction by intra-gastric gavage of glucose resulted in a one -fold increase in glucose levels of
the plasma by comparing groups at 0 minutes with that at -30 minutes (Table. 2). Olive leaves phytosome showed a
reduction of blood glucose levels of 10, 20, 26, and 9% at 30, 60, 90, 120 minutes respectively. Whereas, bitter melon
phytosome showed a reduction of 12, 14, 26, 10% at 30, 60, 90, 120 minutes respectively. Most significant reduction of
glucose levels was observed in the phytosomes of olive leaves and bitter melon and then for glibenclamide drug at 90
minutes.
DISCUSSIONS
The total phenolic compounds of olive leaves and bitter melon extracts were consistency with reported values
from different previous reports [25, 26]. Moreover, it is well known that the activities of the olive leaves and bitter melon
extracts in management chronic diseases, especially diabetes are due to the antioxidant activities of the phenolic
compounds.In this study, the quantitative phytochemicals of each extract responsible for the observed anti-hyperglycemic
activities have not been isolated or determined, and further work is now ongoing in our laboratory to determine the
phytochemicals content and bioavailability rate.
Microscopic scanning of the produced phytosomes showed a cell-like structure that was strongly in agreement
with previous studies [27, 28]. The cell-like the structure of the phytosome resulted from the action of
phosphatidyl-choline in which they bind to the phyto-constituents of herbal extract, and engulfing it to produce
microsphere which is called phytosome [27]. Therefore, using phosphatidy l-choline in the phytosome structure is to make
the structure highly similar to the cell membrane composition that facilitates and accelerate the absorption of the plants
material into blood circulation [29].
The OGTT is an important and very necessary parameter to determine the rate of the body ability to consume
glucose, and also gives information about the efficacy of a drug and plant extracts in acute hyperglycemia [24]. In this
study, olive leaves and bitter melon extracts provided in the phytosome form at the dose of 20mg/kg reported higher
glucose reduction of hyperglycemic rats in comparison to non- phytosome form. With regard to the hypoglycemic
activities of the tested plants, the olive leaves constituent responsible for these effects is oleuropein and hydroxytyrosol,
which are the most phenolic component [30], whereas bitter melon extract contents appear to have similarities with the
www.iaset.us editor@iaset.us
36 Bandar Hamadneh, Hayder AL-Domi & Malik Haddadin
structure to the animal insulin-like charantin [31, 32]. Glucose levels were reduced by phytosome form could be attributed
to the enhancement of the phenolic compounds of the extracts. In previous studies, the phytosome structure improves the
levels of polyphenolic constituents in the blood serum with at least 2-6 times more than non phytosome form. This is
actually attributed to the chemical bondages between polyphenol and phosphatidyl-choline molecules [33].
To our knowledge, the finding of this study constitutes the first experimental evidence of the reducing effect of
olive leaves and bitter melon phytosomes preparation on glycaemia in laboratory rodents. Moreover, potency and efficacy
of it may require further investigation.
CONCLUTIONS
Phytosome structure is a novel delivery system that overcomes the problems that are associated with the using of
plants extracts such as poor stability in gastric environment, herbal toxicity, poor pharmacological activity, physical and
chemical degradation, and high doses of ingredients that affect the safety and efficacy of the extracts. Olive leaves and
bitter melon extracts provided in a phytosome form resulted significant anti-hyperglycemic activities in the
glucose- induced hyperglycemic rats in compared to non-phytosome form. Further studies are required to monitor the
bioavailability of the active compounds in blood, and other metabolic factors related to the metabolic process of the
diabetes .
ACKNOWLEDGEMENTS
We acknowledge the Deanship of Academic Research of the University of Jordan for funding the study
REFERENCES
1. Canadian Task Force on Preventive Health Care. Recommendations on screening for type 2 diabetes in adults.
Canadian Medical Association Journal. 2012 Oct 16;184(15):1687-96.
2. Sherwin R, Jastreboff AM. Year in diabetes 2012: the diabetes tsunami. The Journal of Clinical Endocrinology &
Metabolism. 2012 Dec 1;97(12): 4293-301.
4. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes
prevalence for 2013 and projections for 2035. Diabetes research and clinical practice. 2014 Feb 1;103(2):
137-49. Chander AP, Reddy RRA and Puchchakayala G. (2011), Hypoglycemic and antidiabetic activity of
glochidion velutinum on streptozotocin-nicotinamide induced Type 2 diabetic rats. Eurpion Journal.
Biological Science.126–130.
5. Jain N, Gupta BP, Thakur N, Jain R, Banweer J, Jain DK, Jain S. Phytosome: a novel drug delivery system for
herbal medicine. Int J Pharm Sci Drug Res. 2010;2(4):224-8.
6. Akram Ahangarpour HT, Jabari A, Nia HM, Heidari H. Antidiabetic and hypolipidemic effects of Dorema
aucheri hydroalcoholic leave extract in streptozotocin-nicotinamide induced type 2 diabetes in male rats.
Iranian journal of basic medical sciences. 2014 Oct;17(10):808.
7. Hays NP, Galassetti PR, Coker RH. Prevention and treatment of type 2 diabetes: current role of lifestyle,
natural product, and pharmacological interventions. Pharmacology & therapeutics. 2008 May 1;118(2):181-91.
8. Patel J, Patel R, Khambholja K, Patel N. An overview of phytosomes as an advanced herbal drug delivery system.
Asian J Pharm Sci. 2009 Apr;4(6):363-71.
10. Komaki E, Yamaguchi S, Kinoshita M, Kakehi K, Ohta Y, Tsukada Y. Identification of anti-α-amylase components
from olive leaf extracts. Food Science and Technology Research. 2003;9(1):35-9.
11. Horax R, Hettiarachchy N, Islam S. Total phenolic contents and phenolic acid constituents in 4 varieties of bitter
melons (Momordica charantia) and antioxidant activities of their extracts. Journal of food science. 2005 May
1;70(4).
12. Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety.
American Journal of Health-System Pharmacy. 2003 Feb 15;60(4):356-9.
13. Pawar HA, Bhangale BD. Phytosome as a novel biomedicine: a microencapsulated drug delivery system.
Journal of Bioanalysis & Biomedicine. 2015 Jan 1;7(1):6.
14. EHIGIE, LEONARD ONA, RAPHAEL EMUEBIE OKONJI, and ADEOLA FOLASADE EHIGIE.
"PURIFICATION AND CHARACTERIZATION OF RHODANESE FROM THE LEAVE OF BITTER MELON
(MOMORDICA CHARANTIA)."
15. Yadav M, Bhatia VJ, Doshi G. Novel techniques in herbal drug delivery systems. Int J Pharm Sci Rev Res.
2014;28(2):83-9.
16. Arora S, Kaur P. Preparation and characterization of phytosomal-phospholipid complex of p. amarus and its
tablet formulation.
17. Haddadin MS. Effect of olive leaf extracts on the growth and metabolism of two probiotic bacteria of intestinal
origin. Pakistan Journal of Nutrition. 2010;9(8):787-93.
18. Sihem D, Samia D, Gaetano P, Sara L, Giovanni M, Hassiba C, Laura G, Noureddine HA. In vitro antioxidant
activities and phenolic content in crop residues of Tunisian globe artichoke. Scientia Horticulturae. 2015 Jul
16;190:128-36.
19. Stankovic MS. Total phenolic content, flavonoid concentration and antioxidant activity of Marrubium peregrinum
L. extracts. Kragujevac J Sci. 2011 Jan 1;33(2011):63-72.
20. Zhishen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging
effects on superoxide radicals. Food chemistry. 1999 Mar 1;64(4):555-9.
www.iaset.us editor@iaset.us
38 Bandar Hamadneh, Hayder AL-Domi & Malik Haddadin
22. Kareparamban JA, Nikam PH, Jadhav AP, Kadam VJ. Phytosome: a novel revolution in herbal drugs. IJRPC.
2012;2(2):299-310.
23. Verma VK, Sarwa KK, Kumar A, Zaman MK. Comparison of hepatoprotective activity of Swertia chirayita and
Andrographis paniculata plant of North–East India against CCl4 induced hepatotoxic rats. Journal of Pharmacy
Research. 2013 Jul 1;7(7):647-53.
24. Domekouo UL, Longo F, Tarkang PA, Tchinda AT, Tsabang N, Donfagsiteli NT, Tamze V, Kamtchouing P,
Agbor GA. Evaluation of the antidiabetic and antioxidant properties of Morinda lucida stem bark extract in
streptozotocin intoxicated rats. Pakistan journal of pharmaceutical sciences. 2016 May 1;29(3).
25. Acharya NS, Parihar GV, Acharya SR. Phytosome: Novel Approach for Delievering Herbal Extract With
Improved Bioavailability, Pharma Science Monitor. An International Journal of Pharmaceutical Sciences.
2011;1:144-60.
26. Amin T, Bhat SV. A review on phytosome technology as a novel approach to improve the bioavailability of
nutraceuticals. Int J Adv Res Technol. 2012 Aug;1(3):1-5.
27. Aljohi A, Matou-Nasri S, Ahmed N. Antiglycation and antioxidant properties of Momordica charantia. PloS one.
2016 Aug 11;11(8):e0159985.
28. Amit P, Tanwar YS, Rakesh S, Poojan P. Phytosome: Phytolipid drug delivery system for improving
bioavailability of herbal drug. J. Pharm. Sci. Biosci. Res. 2013;3(2):51-7.
29. Dekdouk N, Malafronte N, Russo D, Faraone I, De Tommasi N, Ameddah S, Severino L, Milella L. Phenolic
compounds from Olea europaea L. possess antioxidant activity and inhibit carbohydrate metabolizing enzymes in
vitro. Evidence-Based Complementary and Alternative Medicine. 2015;2015.
30. de Bock M, Derraik JG, Brennan CM, Biggs JB, Morgan PE, Hodgkinson SC, Hofman PL, Cutfield WS.
Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a
randomized, placebo-controlled, crossover trial. PloS one. 2013 Mar 13;8(3):e57622.
31. Choubey A. Phytosome-A Novel Approach for Herbal Drug Delivery. International Journal of Pharmaceutical
Sciences and Research. 2011 Apr 1;2(4):807.
32. El-Said SM, Al-Barak AS. Extraction of insulin like compounds from bitter melon plants. Am. J. Drug Discovery
Dev. 2011;1:1-7.
33. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability.
The American journal of clinical nutrition. 2004 May 1;79(5):727-47.
34. Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin–phospholipid complex and the study on its
pharmacokinetics in rats. International journal of pharmaceutics. 2006 Jan 3;307(1):77-82.
APPENDIES
Table 1: Total Polyphenols, Total Flavonoids, and Total Tannins Extracted from Olive Leaves/Bitter Melon
Total Polyphenols Total Flavonoids Total Tannins
Plant*
(mg GAE/g Extract) (mg Rutin /g Extract) (mg GAE /Extract)
Olive leaves extract 294 ± 6.1 18.18± 5.15 27.35± 10.3
Bitter melon extract 172± 7.45 13.46± 3.55 8.24± 4.6
*Values are represented as the mean of three replicates ± SEM
Table 2: Effect of Provide Olive Leaves and Bitter Melon Extracts and
Phytosomes on the Glucose-Induced Hyperglycemia in Rats
-30Minute 0 Minute 30 Minute 60 Minute
90 Minute 120 Minute
Blood Blood Blood
Treatment Blood Glucose Blood Glucose Blood Glucose
Glucose Glucose Glucose
(mg/dl) % (mg/dl) % (mg/dl) %
(mg/dl) ** (mg/dl) % (mg/dl) %
a a
142.8 ±1.20 - 136.8 ± 0.80 - 125.8 ± 0.58 112.6 ±1.75 a -
Control 76.2 ± 0.86 152.2 ± 0.86 a 76 a
9 6 -11 13
Bitter melon b b b 125.2±1.36 a 112.8 ±1.43 a -
74.2 ±1.16 144.8 ± 0.86 71 136.4 ±1.40 -8 129.2±1.28 -7
extract -4 12
Bitter melon b 133.8 ±1.20 b - 119.8 ±1.02 c - 93.4±1.36 b - 83.2 ±1.28 b -
74.0 ± 0.71 145.4 ±1.25 71
phytosome 12 14 26 10
Glibenclamide b 133.6 ±1.36 b - 111.2 ±1.66 d - 91.2 ±1.16 b 75.6 ±1.50 c -
74.6 ±1.33 145.2 ±1.11 71
drug 12 22 -20 16
Olive leaves b 141.6 ± 0.93 a - b 125.0 ±1.52 115.0 ±1.52 a -
76.8± 0.66 145.8 ±1.39 69 132.4 ±1.54 -9 a
extract 4 -7 10
Olive leaves b 135.0 ±1.22 - 115.0 ±1.70 - 89.0±3.18 b
b d
74.6±0.51 144.6 ±1.36 70 79.8 ±1.02 b -9
phytosome 10 20 -26
p-value 0.205 0.001* <0.001* <0.001* <0.001* <0.001*
*One-Way ANOVA, all Pair-wise comparisons were made using Duncan’s Multiple Range Test (DMRT) post-hoc test,
and is significant at p<0.001.
** Data are presented as mean ±SEM
%Degree of blood glucose levels reduction
www.iaset.us editor@iaset.us